Successful outcome of share issue in Paindrainer AB
LUND, SWEDEN – Paindrainer AB announces that the company successfully completed a share issue of 10 MSEK.The share issue enables Paindrainer AB to fully initiate the commercial rollout of their unique drug-free, digital self-management tool for chronic pain patients. Furthermore, it enables the company to accelerate the integration of wearables to the product, which will further improve the user friendliness and engagement of the patient and accuracy of the input data. “Having achieved outstanding clinical evidence, commercialization of Paindrainer is our top priority in 2023. There is a